FDA Inspection
Zhejiang Haizhou Pharmaceutical Co., Ltd.Zhejiang Haizhou Pharmaceutical Co., Ltd. – FDA Inspection, Jan 18, 2019
Record Details
This FDA Inspection record concerns Zhejiang Haizhou Pharmaceutical Co., Ltd., with an inspection on January 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 139402a5-b290-46e5-816b-f7d5f1e6ec75
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1078048
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Haizhou Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Haizhou Pharmaceutical Co., Ltd.
- FDA Inspection 1271224 - 2025-04-18
- FDA Inspection 893991 - 2014-08-07
- FDA Inspection 742581 - 2011-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.